Cite
HARVARD Citation
Varisco, V. et al. (2014). SAT0258 Low Risk of Hepatitis B Virus Surface Antigen Seroreversion in Hbsag Negative, Anti-Hbc Positive Carriers Undergoing Rituximab for Rheumatoid Arthritis. Annals of the rheumatic diseases. pp. 686-687. [Online].